Company / Inventory
Esperion Therapeutics, Inc. Inventory History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$105.1M
FY2025
5-year range
$34.4M / $105.1M
FY2021-FY2025
Trend
+11.3%
vs FY2024
Sector context
#44 of 105
Health Care
What the data says
At $105M, Esperion Therapeutics, Inc.'s inventory ranks #44 of 105 in the Health Care sector. Inventory has increased for 6 consecutive years, from $0 in FY2019 to $105M in FY2025.
Based on SEC 10-K filings.
$105M in FY2025 with a 5-year CAGR of +45.5%.
Improved from $66M to $105M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +44.0%
- 5-Year CAGR
- +45.5%
- 10-Year CAGR
- -
Sector benchmark
#44 of 105 in Health CareTop 42% of 105This company $105.1M Sector average $885.3M
▼
-88.1% below sector average
Key checks
Key Insights
- Esperion Therapeutics, Inc.'s inventory has grown for 5 consecutive years.
- 5-year CAGR of +45.5%, indicating consistent growth.
- In FY2025, inventory increased 11.3% year-over-year.
- Ranks #44 out of 105 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -1.60 (distress zone, below 1.8 threshold)
- Negative profit margin: -15.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $105.1M | +11.3% |
| FY2024 | $94.5M | +44.0% |
| FY2023 | $65.6M | +86.4% |
| FY2022 | $35.2M | +2.3% |
| FY2021 | $34.4M | +113.2% |
| FY2020 | $16.1M | - |
| FY2019 | $0 | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026